EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Silver Nanoparticle–Antibiotic Combinations: A Strategy to Overcome Bacterial Resistance in Escherichia coli, Salmonella Enteritidis and Staphylococcus aureus

Mariana Homem de Mello Santos iD, Thiago Hideo Endo iD, Sara Scandorieiro iD, Wander Rogério Pavanelli iD, Renata Katsuko Takayama Kobayashi iD, Gerson Nakazato iD

Antibiotics · 24.09.2025 · 14 (10) · 960

DOI: 10.3390/antibiotics14100960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 24.09.2025. Verfasst von Mariana Homem de Mello Santos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Basic and Applied Bacteriology, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina, Londrina …. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Bacterial resistance to antimicrobials is a major global health challenge, limiting the effectiveness of conventional therapies and complicating infection control. The aim of this study was to investigate the antibacterial potential of biologically synthesized silver nanoparticles (Bio-AgNP), alone and in combination with ampicillin (AMP) and enrofloxacin (ENRO), against multidrug-resistant (MDR) bacterial isolates of clinical and veterinary relevance.

Methods

The antibacterial activity of Bio-AgNP, AMP, and ENRO, alone or in combination, was assessed against reference strains and MDR isolates of Escherichia coli, Salmonella enterica serovar Typhimurium and Enteritidis, and Staphylococcus aureus. Minimum inhibitory concentration (MIC) values were determined, and bacterial tolerance to prolonged antimicrobial exposure was evaluated. Additionally, assays were conducted to explore potential mechanisms of action, including cell membrane permeability and oxidative stress induction.

Results

All bacterial strains developed increased MIC values after prolonged exposure to conventional antibiotics, confirming resistance. Only E. coli developed resistance to Bio-AgNP. Notably, the Bio-AgNP + AMP combination effectively restored susceptibility in E. coli, while only S. Enteritidis developed resistance to this combination upon prolonged exposure. The synergistic effect of Bio-AgNP with conventional antibiotics significantly reduced bacterial growth within two hours, compared with longer times observed in monotherapy. Mechanistic analysis suggested that the combinations increased membrane permeability, facilitating antibiotic entry.

Conclusions

Bio-AgNPs combined with AMP or ENRO enhanced antibacterial activity and overcame resistance in MDR isolates, representing a promising therapeutic alternative. The biological synthesis of Bio-AgNPs, capped with organic biomolecules, supports their potential as safe adjuvants to conventional antibiotics in combating MDR bacterial infections.

Schlagwörter

Stichwörter der Autor:innen

combination therapy and mechanism of actionnanotechnologysynergism

Autor:innen und Institutionen

  • Laboratory of Basic and Applied Bacteriology, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina, Londrina 86057-970, Brazil.
  • Laboratory of Innovation and Cosmeceutical Technology, Department of Pharmaceutical Sciences, Center of Health Sciences, Hospital Universitário de Londrina, Londrina 86038-350, Brazil.
  • Laboratory of Experimental Protozoology, Department of Pathological Sciences, Center of Biological Sciences, Universidade Estadual de Londrina, Londrina 86057-970, Brazil.

ORCID-Profile: Mariana Homem de Mello Santos, Thiago Hideo Endo, Sara Scandorieiro, Wander Rogério Pavanelli, Renata Katsuko Takayama Kobayashi, Gerson Nakazato

Zitieren

APA

Santos, M. H. M., Endo, T. H., Scandorieiro, S., Pavanelli, W. R., Kobayashi, R. K. T., & Nakazato, G. (2025). Silver Nanoparticle–Antibiotic Combinations: A Strategy to Overcome Bacterial Resistance in Escherichia coli, Salmonella Enteritidis and Staphylococcus aureus. Antibiotics, 14(10), 960. https://doi.org/10.3390/antibiotics14100960

Vancouver

Santos MHM, Endo TH, Scandorieiro S, Pavanelli WR, Kobayashi RKT, Nakazato G. Silver Nanoparticle–Antibiotic Combinations: A Strategy to Overcome Bacterial Resistance in Escherichia coli, Salmonella Enteritidis and Staphylococcus aureus. Antibiotics. 2025;14(10):960. doi:10.3390/antibiotics14100960

BibTeX
@article{Santos2025,
  author = {Santos, Mariana Homem de Mello and Endo, Thiago Hideo and Scandorieiro, Sara and Pavanelli, Wander Rogério and Kobayashi, Renata Katsuko Takayama and Nakazato, Gerson},
  title = {Silver Nanoparticle–Antibiotic Combinations: A Strategy to Overcome Bacterial Resistance in Escherichia coli, Salmonella Enteritidis and Staphylococcus aureus},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {960},
  doi = {10.3390/antibiotics14100960}
}
Kostenlos starten →